1. Home
  2. ACLX
  3. ACLX News

Latest Arcellx Inc. (ACLX) News on October 29, 2025

Gilead dives into ‘in vivo’ cell therapy with $350M buyout of Interius

BioPharma Dive

2 months ago

Gilead dives into ‘in vivo’ cell therapy with $350M buyout of Interius

Arcellx Stock Earns 82 Relative Strength Rating

Investor's Business Daily

10 months ago

Arcellx Stock Earns 82 Relative Strength Rating

Associated Press Finance

2 years ago

Kemper: Q4 Earnings Snapshot

Share on Social Networks: